These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8069670

  • 1. Systemic 3-nitropropionic acid: long-term effects on locomotor behavior.
    Koutouzis TK, Borlongan CV, Scorcia T, Creese I, Cahill DW, Freeman TB, Sanberg PR.
    Brain Res; 1994 May 23; 646(2):242-6. PubMed ID: 8069670
    [Abstract] [Full Text] [Related]

  • 2. Intrastriatal 3-nitropropionic acid: a behavioral assessment.
    Koutouzis TK, Borlongan CV, Freeman TB, Cahill DW, Sanberg PR.
    Neuroreport; 1994 Nov 21; 5(17):2241-5. PubMed ID: 7881036
    [Abstract] [Full Text] [Related]

  • 3. Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model.
    Borlongan CV, Koutouzis TK, Freeman TB, Hauser RA, Cahill DW, Sanberg PR.
    Brain Res Brain Res Protoc; 1997 Aug 21; 1(3):253-7. PubMed ID: 9385062
    [Abstract] [Full Text] [Related]

  • 4. Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats.
    Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, Sanberg PR.
    Brain Res Bull; 1995 Aug 21; 36(6):549-56. PubMed ID: 7538873
    [Abstract] [Full Text] [Related]

  • 5. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease.
    Borlongan CV, Koutouzis TK, Freeman TB, Cahill DW, Sanberg PR.
    Brain Res; 1995 Oct 30; 697(1-2):254-7. PubMed ID: 8593585
    [Abstract] [Full Text] [Related]

  • 6. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC, Hantraye P, Dolan R, Palfi S, Maziére M, Brouillet E.
    Neuroscience; 1997 Jul 30; 79(1):45-56. PubMed ID: 9178864
    [Abstract] [Full Text] [Related]

  • 7. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
    Araujo DM, Hilt DC.
    Neuroscience; 1998 Jan 30; 82(1):117-27. PubMed ID: 9483508
    [Abstract] [Full Text] [Related]

  • 8. Selective A2A receptor antagonist SCH 58261 modulates striatal oxidative stress and alleviates toxicity induced by 3-Nitropropionic acid in male Wistar rats.
    Bortolatto CF, Reis AS, Pinz MP, Voss GT, Oliveira RL, Vogt AG, Roman S, Jesse CR, Luchese C, Wilhelm EA.
    Metab Brain Dis; 2017 Dec 30; 32(6):1919-1927. PubMed ID: 28795281
    [Abstract] [Full Text] [Related]

  • 9. Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease.
    Borlongan CV, Koutouzis TK, Poulos SG, Saporta S, Sanberg PR.
    Cell Transplant; 1998 Dec 30; 7(2):131-5. PubMed ID: 9588595
    [Abstract] [Full Text] [Related]

  • 10. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
    Reynolds DS, Carter RJ, Morton AJ.
    J Neurosci; 1998 Dec 01; 18(23):10116-27. PubMed ID: 9822765
    [Abstract] [Full Text] [Related]

  • 11. Behavioral alterations in Lewis rats following two-day continuous 3-nitropropionic acid administration.
    Newcomb JD, Brown WD, Rodriguez AI, Garbuzova-Davis S, Saporta S, Sanberg PR, Willing AE.
    Neurotox Res; 2005 Nov 01; 8(3-4):259-66. PubMed ID: 16371320
    [Abstract] [Full Text] [Related]

  • 12. Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.
    Akopian G, Crawford C, Beal MF, Cappelletti M, Jakowec MW, Petzinger GM, Zheng L, Gheorghe SL, Reichel CM, Chow R, Walsh JP.
    J Neurosci; 2008 Sep 17; 28(38):9585-97. PubMed ID: 18799690
    [Abstract] [Full Text] [Related]

  • 13. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.
    Alexi T, Hughes PE, Knüsel B, Tobin AJ.
    Exp Neurol; 1998 Sep 17; 153(1):74-93. PubMed ID: 9743569
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 17; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 15. The problem of antipsychotic treatment for functional imaging in Huntington's disease: receptor binding, gene expression and locomotor activity after sub-chronic administration and wash-out of haloperidol in the rat.
    Besret L, Page KJ, Dunnett SB.
    Brain Res; 2000 Jan 17; 853(1):125-35. PubMed ID: 10627316
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M, Khan HA, Elfaki I, Al Deeb S, Al Moutaery K.
    Brain Res Bull; 2005 Sep 30; 67(1-2):161-8. PubMed ID: 16140176
    [Abstract] [Full Text] [Related]

  • 17. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation.
    Kreipke CW, Walker PD.
    Synapse; 2004 Jul 30; 53(1):28-35. PubMed ID: 15150738
    [Abstract] [Full Text] [Related]

  • 18. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M, Borah A, Varghese M, Barman PK, Mohanakumar KP, Usha R.
    Neurochem Int; 2009 Nov 30; 55(6):431-7. PubMed ID: 19410615
    [Abstract] [Full Text] [Related]

  • 19. Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid.
    Eradiri OL, Starr MS.
    Eur J Pharmacol; 1999 Dec 15; 386(2-3):217-26. PubMed ID: 10618473
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis in the striatum of rats following intraperitoneal injection of 3-nitropropionic acid.
    Sato S, Gobbel GT, Honkaniemi J, Li Y, Kondo T, Murakami K, Sato M, Copin JC, Chan PH.
    Brain Res; 1997 Jan 16; 745(1-2):343-7. PubMed ID: 9037431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.